Tenet Healthcare Corp. Hits New 52-Week High of $205.99

Tenet Healthcare Corp. has reached a significant milestone by hitting a new 52-week high of USD 205.99 on October 3, 2025. This achievement underscores the company's strong performance in the hospital industry, particularly as it has recorded a remarkable 47.36% increase over the past year, significantly outperforming the S&P 500, which has seen a gain of 17.82% during the same period.
With a market capitalization of USD 26,308 million, Tenet Healthcare operates as a mid-cap entity within the healthcare sector. The company boasts a price-to-earnings (P/E) ratio of 10.00, indicating a favorable valuation compared to many peers. Additionally, Tenet's return on equity stands at an impressive 67.40%, reflecting its effective management and profitability.

Despite a debt-to-equity ratio of 2.81, which suggests a higher reliance on debt financing, the company has maintained a robust financial position. Tenet Healthcare's price-to-book ratio is recorded at 7.02, further illustrating its market valuation. As it continues to navigate the healthcare landscape, this new high marks a noteworthy point in its ongoing performance trajectory.